Beleggen.nl Markt MonitorMarkt Monitor

Pharming januari 2018

11.235 Posts
Pagina: «« 1 ... 383 384 385 386 387 ... 562 »» | Laatste | Omlaag ↓
  1. [verwijderd] 23 januari 2018 12:51
    Is dat de noorse variant van het US bedrijf?
    Wel de hele info plaatsen ajb....
    Je bericht gaat enkel over Q4

    +++++++++++++++++++

    Johnson & Johnson beats by $0.02, beats on revenue
    Jan. 23, 2018 6:42 AM ET|About: Johnson & Johnson (JNJ)|By: Mamta Mayani, SA News Editor

    Johnson & Johnson (NYSE:JNJ): Q4 EPS of $1.74 beats by $0.02.

    Revenue of $20.2B (+11.5% Y/Y) beats by $130M.

    Shares +0.27% PM.

    Net loss and diluted loss per share for the fourth quarter of 2017 were $10.7 billion and $3.99, respectively. Fourth-quarter 2017 net loss included after-tax intangible amortization expense of approximately $0.9 billion and a net charge for after-tax special items of approximately $14.6 billion. Included in these special items is a provisional amount of approximately $13.6 billion associated with the recent enactment of tax legislation.** Fourth-quarter 2016 net earnings included after-tax intangible amortization expense of approximately $0.3 billion and a net charge for after-tax special items of approximately $0.3 billion. Excluding after-tax intangible amortization expense and special items, adjusted net earnings for the current quarter were $4.8 billion and adjusted diluted earnings per share were $1.74, representing increases of 9.5% and 10.1%, respectively, as compared to the same period in 2016.* On an operational basis, adjusted diluted earnings per share increased 5.7%.* A reconciliation of non-GAAP financial measures is included as an accompanying schedule.

    seekingalpha.com/pr/17053129-johnson-...

    Net loss and diluted loss per share for the fourth quarter of 2017 were $10.7 billion and $3.99, respectively. Fourth-quarter 2017 net loss included after-tax intangible amortization expense of approximately $0.9 billion and a net charge for after-tax special items of approximately $14.6 billion. Included in these special items is a provisional amount of approximately $13.6 billion associated with the recent enactment of tax legislation.** Fourth-quarter 2016 net earnings included after-tax intangible amortization expense of approximately $0.3 billion and a net charge for after-tax special items of approximately $0.3 billion. Excluding after-tax intangible amortization expense and special items, adjusted net earnings for the current quarter were $4.8 billion and adjusted diluted earnings per share were $1.74, representing increases of 9.5% and 10.1%, respectively, as compared to the same period in 2016.* On an operational basis, adjusted diluted earnings per share increased 5.7%.* A reconciliation of non-GAAP financial measures is included as an accompanying schedule.
    Net earnings and diluted earnings per share for the full-year 2017 were $1.3 billion and $0.47, respectively.
  2. [verwijderd] 23 januari 2018 12:58
    quote:

    Teddieke schreef op 23 januari 2018 12:38:

    [...]

    Daar zou ik graag in investeren maar ik kan geen broker vinden waar ik in HMMJ kan handelen.
    DeGiro kon het, maar daar is de handel in die ETF geschorst omwille van nieuwe regelgeving.

    Ik wacht met smart totdat dit weer mogelijk is.
  3. [verwijderd] 23 januari 2018 13:02
    quote:

    Theo3 schreef op 23 januari 2018 12:19:

    Auroa cannabis Dt. Cannabis ago.n Weedmd.inc
    Heb jij Weedmd realtime?
    Zo nee doe jij het op gevoel, uhh ik bedoel aandeeltjes handelen ;-)
  4. nescio 23 januari 2018 13:08
    quote:

    Deneus schreef op 23 januari 2018 12:50:

    lijkt wel een koffieshop hier met al die cannabis lol.
    "C" coffeeshop. Neus
  5. [verwijderd] 23 januari 2018 13:08
    quote:

    geldding2 schreef op 23 januari 2018 12:35:

    [...]

    Portefeuilleoverzicht 23-01-2018 12:30:01Bijgewerkt tot:
    CPT
    Vermogen Portefeuille Kas Bestedingsruimte
    € 592.009,25 € 591.199,20 € 810,05

    Ongerealiseerd resultaat Totaal
    ?
    38,69% € 164.933,28

    Portefeuilleoverzicht 23-01-sint juttemis 11:11:11Bijgewerkt tot:
    CPT
    Vermogen Portefeuille Kas Bestedingsruimte
    € 1.592.009,20 €1.111.111,11 € 480.898.09

    Ongerealiseerd resultaat Totaal
    ?
    1.111,11% €151.151.151,51

    O shit! did I mention it is a papertrading account?
  6. RW1963 23 januari 2018 13:15
    quote:

    Theo3 schreef op 23 januari 2018 12:20:

    Aurora is de beste op dit moment
    Heb ik ook
  7. niccienieuw 23 januari 2018 13:18
    quote:

    NEVDK schreef op 23 januari 2018 13:04:

    [...]

    oppassen is al x7 gegaan .... meer of minder zeg ik niet..
    Ik hoop dat je het niet erg vind, maar ik ben nog zo'n leek en wil dan toch graag doorvragen. Hoop dat je antwoordt. Verwacht je zoiets als bij probiodrug? Prijs opstuwen en dan groot aandeelhouders ineens eruit?
  8. forum rang 4 torro 23 januari 2018 13:27
    quote:

    twopence schreef op 23 januari 2018 13:23:

    Nou,nou, Pharming in het rood. Als dat maar goed gaat.
    buy on the ......
11.235 Posts
Pagina: «« 1 ... 383 384 385 386 387 ... 562 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.018
AB InBev 2 5.504
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.697
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 265
Accsys Technologies 23 10.712
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 189
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.752
Aedifica 3 916
Aegon 3.258 322.861
AFC Ajax 538 7.088
Affimed NV 2 6.297
ageas 5.844 109.893
Agfa-Gevaert 14 2.050
Ahold 3.538 74.339
Air France - KLM 1.025 35.047
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.042
Alfen 16 24.867
Allfunds Group 4 1.473
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.263
AMG 971 133.390
AMS 3 73
Amsterdam Commodities 305 6.690
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.008
Apollo Alternative Assets 1 17
Apple 5 383
Arcadis 252 8.780
Arcelor Mittal 2.033 320.723
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.305
Aroundtown SA 1 219
Arrowhead Research 5 9.743
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.182
ASML 1.766 107.492
ASR Nederland 21 4.495
ATAI Life Sciences 1 7
Atenor Group 1 491
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.675
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392